The relationship between aryl hydrocarbon hydroxylase activity and DNA adducts measured by 32P-postlabelling assay in lymphocytes of lung cancer patients

Biomarkers

Volumn 5, Issue 2, 2000, Pages 152-157

  Zhang, Jiusong ^a   Ichiba, Masayoshi ^a   Kiyohara, Chikako ^b   Nakanishi, Yoichi ^b   Takayama, Koichi ^b   Hara, Nobuyuku ^b   Tomokuni, Katsumaro ^a  

^a SAGA UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Aryl hydrocarbon hydroxylase; DNA adduct; Lung cancer

Indexed keywords

3 METHYLCHOLANTHRENE; DNA; ETHOXYRESORUFIN DEETHYLASE; GLUTATHIONE TRANSFERASE; UNSPECIFIC MONOOXYGENASE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DNA ADDUCT; ENZYME ACTIVITY; ENZYME INDUCTION; FEMALE; HUMAN; LUNG CANCER; LUNG SMALL CELL CANCER; LYMPHOCYTE; MALE;

EID: 0034026639     PISSN: 1354750X     EISSN: None     Source Type: Journal    
DOI: 10.1080/135475000230460     Document Type: Article

References (20)

1. ALEXANDROV, K., ROJAS, M., GENESTE, O., CASTEGNARO, M., CAMUS, A. M., PETRUZZELLI, S., GIUNTINI, C. and BARTSCH, H. 1992, An improved fluorometric assay for dosimetry of benzo(a)pyrene diol-epoxide-DNA adducts in smokers' lung: comparisons with total bulky adducts and aryl hydrocarbon hydroxylase activity. Cancer Research, 52, 6248-6253.
2. BARBONE, F., BOVENZI, M., CAVALLIERI, F. and STANTA, G. 1997, Cigarette smoking and histologic type of lung cancer in men. Chest, 112, 1474-1479.
3. 32P-postlabeling assay. Carcinogenesis, 13, 1053-1074.
4. EMERY, A. E. H., ANAND, R. and CANFORD, N. 1978, Aryl hydrocarbon-hydroxylase inducibility in patients with cancer. Lancet, 1, 470-472.
5. FARMER, F. B. 1995, Monitoring of human exposure to carcinogens through DNA and protein adduct determination. Toxicology Letters, 82-83, 757-762.
6. 32P-postlabelling and aryl hydrocarbon hydroxylase activity in lung parenchyma of smokers and ex-smokers. Carcinogenesis, 12, 1301-1305.
7. GUENGERICH, F. P. 1988, Roles of cytochrome P450 enzymes in chemical carcinogenesis and cancer chemotherapy. Cancer Research, 48, 2946-2954.
8. HARRIES, L. W., STUBBINS, M. J., FORMAN, D., HOWARD, G. C. W. and WOLF, C. R. 1997, Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis, 18, 641-644.
9. IARC: International Agency for Research on Cancer 1986, IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. No. 38, Tobacco Smoking (Lyon: IARC).
10. ICHIBA, M., WANG, Y., OISHI, H., IYADOMI, M., SHONO, N. and TOMOKUNI, K. 1996, Smoking-related DNA adducts and genetic polymorphism for metabolic enzymes in human lymphocytes. Biomarkers, 1, 211-214.
11. IOANNIDES, C. and PARKE, D. V. 1990, The cytochrome P450 1 gene family of microsomal hemoproteins and their role in the metabolic activation of chemicals. Drug Metabolism Reviews, 22, 1-85.
12. KARRI, N. T., POKELA, R., NUUTINEN, L. and PELKONEN, O. 1987, Aryl hydrocarbon hydroxylase in lymphocytes and lung tissue from lung cancer patients and controls. International Journal of Cancer, 39, 565-570.
13. KATOH, T., NAGATA, N., KURODA, Y., ITOH, H., KAWAHARA, A., KUROKI, N., OOKUMA, R. and BELL, D. A. 1996, Glutathione S-transferase M1 (GSTM1) and T1 (GST1) genetic polymorphism and susceptibility to gastric and colorectal adenocarcinoma. Carcinogenesis, 17, 1855-1859.
14. KIYOHARA, C. and HIROHATA, T. 1997, Environmental factors and aryl hydrocarbon hydroxylase activity (CYP1A1 phenotype) in human lymphocytes. Journal of Epidemiology, 7, 244-250.
15. KIYOHARA, C., MOHRI, N., HIROHATA, T., HARAGUCHI, K. and MASUDA, Y. 1990, In vitro effect of methylsulfonyl polychlorinated biphenyls and 7, 8-benzoflavone on aryl hydrocarbon hydroxylase activity in human lymphoblastoid cells. Pharmacology and Toxicology, 66, 273-276.
16. KIYOHARA, C., TANAKA, K. and HIROHATA, T. 1998, Effect of seasonal change on aryl hydrocarbon hydroxylase activity in human lymphocytes in a Japanese population. Medical Science Research, 26, 75-78.
17. KIYOHARA, C., ICHIBA, M., ZHANG, J., NAKANISHI, Y., TAKAYAMA, K., HARA, N. and HIROHATA, T. 1999, Relationship between aromatic-DNA adduct levels and inducibility of the drug metabolizing enzyme aryl hydrocarbon hydroxylase in lymphocytes. Medical Science Research, 27, 651-655.
18. KOURI, R. E., MCKINNEY, C. E., SLOMIANY, D. J., SNODGRASS, D. R., WRAY, N. P. and MCLEMORE, T. L. 1982, Positive correlation between high aryl hydrocarbon hydroxylase activity and primary lung cancer as analyzed in cryopreserved lymphocytes. Cancer Research, 42, 5030-5037.
19. LIEBERMAN, J. 1978, Aryl hydrocarbon hydroxylase in bronchogenic carcinoma. New England Journal of Medicine, 298, 686-691.
20. 32P-postlabeling test for structurally diverse DNA adducts. Carcinogenesis, 7, 1543-1551.